MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1177/03946320261427990

Медицинская библиотека · International journal of immunopathology and pharmacology · 2026

Outcomes of isoniazid preventive therapy in pregnant women living with HIV: A systematic review and meta-analysis.

Shahid Sufyan, Karimi Hasiba, Ahmad Bilal, Hafeez Usama, Ayalew Biruk Demisse, Abdullah

Систематический обзорМетаанализСтатьяПеревод в очереди

Аннотация

OBJECTIVE

To evaluate the safety and effectiveness of isoniazid preventive therapy (IPT) in pregnant women living with HIV (WLWH) through a systematic review and meta-analysis.

INTRODUCTION

Isoniazid preventive therapy (IPT) is recommended for preventive treatment of tuberculosis in high risk groups. However, evidence on its role in pregnant WLWH remains scarce.

METHODS

We performed a systematic review and meta-analysis to pool randomized controlled trials (RCTs) as well as non-randomized studies (NRS) where IPT was administered to pregnant WLWH (PROSPERO ID: CRD42024618836). PubMed, Embase, and Cochrane Central databases were searched for relevant articles, until November 15, 2024. Statistical analysis was performed using R Software v4.4.1 and a random-effects model was applied to pool risk ratios (RRs) along with 95% confidence intervals.

RESULTS

Five studies with a total of 45,402 patients (mean age = 30 years) were included. The risk of maternal mortality was significantly decreased in pregnant WLWH exposed to IPT compared with the control group (RR 0.42; 95% CI 0.20-0.92; p = 0.03). However, the risks of other outcomes including composite adverse pregnancy outcome (RR 0.90; 95% CI 0.56-1.43; p = 0.66), prematurity (RR 0.86; 95% CI 0.46-1.60; p = 0.63), low birthweight (RR 0.99; 95% CI 0.69-1.42; p = 0.95), very low birthweight (RR 1.28; 95% CI 0.39-4.23; p = 0.55), congenital anomalies (RR 1.48; 95% CI 0.59-3.75; p = 0.41), and hepatotoxicity (RR 0.99; 95% CI 0.71-1.37; p = 0.93) were comparable between the two groups.

CONCLUSION

IPT in pregnant WLWH significantly reduces maternal mortality without increasing adverse pregnancy outcomes. These findings support the continued use of IPT during pregnancy, with careful monitoring for hepatotoxicity, and highlight its potential role as an important maternal health intervention in high TB/HIV burden regions.

Для цитирования: Shahid Sufyan, Karimi Hasiba, Ahmad Bilal, Hafeez Usama, Ayalew Biruk Demisse, Abdullah. Outcomes of isoniazid preventive therapy in pregnant women living with HIV: A systematic review and meta-analysis.. International journal of immunopathology and pharmacology. 2026. DOI: 10.1177/03946320261427990.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.